Dyslipidemias Clinical Trials

41 recruiting

Dyslipidemias Trials at a Glance

41 actively recruiting trials for dyslipidemias are listed on ClinicalTrialsFinder across 6 cities in 17 countries. The largest study group is Not Applicable with 15 trials, with the heaviest enrollment activity in Seoul, Kapolei, and Athens. Lead sponsors running dyslipidemias studies include CRISPR Therapeutics AG, Harvard School of Public Health (HSPH), and University of Georgia.

Browse dyslipidemias trials by phase

Treatments under study

About Dyslipidemias Clinical Trials

Looking for clinical trials for Dyslipidemias? There are currently 41 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Dyslipidemias trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Dyslipidemias clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 41 trials

Recruiting

Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa

ObesityCardiovascular DiseasesChronic Kidney Diseases+8 more
Swiss Tropical & Public Health Institute1,200 enrolled1 locationNCT05881447
Recruiting
Not Applicable

Group Medical Visits for Patients With Dyslipidemia

Dyslipidemias
Université de Sherbrooke288 enrolled1 locationNCT07543718
Recruiting

The Bialystok Bariatric Surgery Study

Diabetes MellitusObesityMetabolic Syndrome+1 more
Medical University of Bialystok1,000 enrolled1 locationNCT04634591
Recruiting
Phase 2

Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels

Dyslipidemias
NewAmsterdam Pharma69 enrolled1 locationNCT06496243
Recruiting

Efficacy and Safety of Pitavastatin/Ezetimibe in Dyslipidemia Patients With Metabolic Syndrome: An Observational Study

Dyslipidemias
JW Pharmaceutical10,000 enrolled1 locationNCT07523971
Recruiting
Phase 1

A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

HypercholesterolaemiaMetabolic DiseaseDyslipidemias+7 more
CRISPR Therapeutics AG90 enrolled18 locationsNCT07491172
Recruiting
Phase 2

Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia

Dyslipidemias
Ribocure Pharmaceuticals AB120 enrolled4 locationsNCT06797401
Recruiting
Not Applicable

PILI 'Āina Household

HypertensionType 2 DiabetesOverweight and Obesity+1 more
University of Hawaii210 enrolled2 locationsNCT06526273
Recruiting
Not Applicable

'Ai Pono Cooking Demonstrations

HypertensionType 2 DiabetesOverweight and Obesity+1 more
University of Hawaii1,780 enrolled2 locationsNCT06526650
Recruiting

Taining Golden Lake Comprehensive Chronic Disease Management Initiative

SarcopeniaDiabetes MellitusHypertension+4 more
First Affiliated Hospital of Fujian Medical University20,000 enrolled1 locationNCT07308314
Recruiting
Early Phase 1

Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity

ObesityDyslipidemias
University of Connecticut130 enrolled1 locationNCT05700916
Recruiting
Phase 2

Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

Cardiovascular DiseasesHIV InfectionsAtherosclerosis+1 more
Priscilla Hsue, MD121 enrolled3 locationsNCT05488431
Recruiting

Lipid Testing After Myocardial Infarction at the Montreal Heart Institute

Myocardial InfarctionDyslipidemiasLipid Testing
Montreal Heart Institute100 enrolled2 locationsNCT06388668
Recruiting

Military Health and Nutrition Examination Study

Cardiovascular DiseasesHypertensionType 2 Diabetes+1 more
Pennington Biomedical Research Center650 enrolled3 locationsNCT06380322
Recruiting

Gut Microbiota in Metabolic Surgery

Cardiovascular DiseasesHypertensionType 2 Diabetes+3 more
Vanderbilt University Medical Center300 enrolled1 locationNCT05000996
Recruiting

Retinal Vascular Manifestations in Patients With Common Internal Diseases on OCTA Tomography Angiography

Diabetes MellitusHypertensionDyslipidemias
Beijing Tongren Hospital300 enrolled1 locationNCT05644548
Recruiting
Not Applicable

Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy

DyslipidemiasPeripheral Vascular DiseasesPeripheral Artery Disease
Brigham and Women's Hospital400 enrolled1 locationNCT06300450
Recruiting
Not Applicable

Effects of a Digital Health Application (Lipodia) on LDL-cholesterol Levels

DyslipidemiasHypercholesterolemia
Gaia AG272 enrolled1 locationNCT05988866
Recruiting

A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe

DyslipidemiasHypercholesterolemia
Ahn-Gook Pharmaceuticals Co.,Ltd4,500 enrolled1 locationNCT07083206
Recruiting
Not Applicable

Culturally Adapted Dietary Clinical Trial in PR

ObesityHypertensionDiabetes Mellitus, Type 2+4 more
Harvard School of Public Health (HSPH)250 enrolled1 locationNCT05962372